Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of TP-03 (LIBRA Study) in blepharitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• TP-03

Snippet

Sponsor: LianBio LLC | Conditions: Blepharitis | Phase 3 | Status: COMPLETED